Mallinckrodt Announces UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Adults GuruFocus.com
New Data Demonstrates That NATESTO® Increases Serum Testosterone and Improves Symptoms While Maintaining Normal Semen Parameters in Men With Low Testosterone Through Six Months Business Wire
New Data Demonstrates That NATESTO® Increases Serum Testosterone and Improves Symptoms While Maintaining Normal Semen Parameters in Men With Low Testosterone Through Six Months Business Wire
New Data Demonstrates That NATESTO® Increases Serum Testosterone and Improves Symptoms While Maintaining Normal Semen Parameters in Men With Low Testosterone Through Six Months Business Wire